Want to track RDNT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
3 Reasons Why Growth Investors Shouldn't Overlook RadNet (RDNT)
RadNet (RDNT) could produce exceptional returns because of its solid growth attributes.
Zacks | 1 year ago
RadNet: Qualified Growth Route, Still Undervalued
RadNet, Inc. shares continue to show strength, having compounded by 184% since 2022. Q1 FY 2024 earnings showed growth in the Digital Health segment and increased MRI, CT, and PET/CT volumes. Management has increased its outlook on full-year revenues and projects $1.67-$1.7 billion in revenue for the year.
Seekingalpha | 1 year ago
All You Need to Know About RadNet (RDNT) Rating Upgrade to Strong Buy
RadNet (RDNT) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Zacks | 1 year ago
